Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 9-((2-hydroxyethoxy)methyl)guanine
2. Aci Sanorania
3. Aci-sanorania
4. Acic
5. Aciclobeta
6. Aciclostad
7. Aciclovir
8. Aciclovir Alonga
9. Aciclovir Sanorania
10. Aciclovir Von Ct
11. Aciclovir-sanorania
12. Acifur
13. Acipen Solutab
14. Acivir
15. Activir
16. Acyclo V
17. Acyclo-v
18. Acycloguanosine
19. Acyclovir
20. Alonga, Aciclovir
21. Antiherpes Creme
22. Avirax
23. Cicloferon
24. Clonorax
25. Cusiviral
26. Genvir
27. Herpetad
28. Herpofug
29. Herpotern
30. Herpoviric
31. Isavir
32. Laciken
33. Mapox
34. Maynar
35. Milavir
36. Opthavir
37. Sodium, Acyclovir
38. Solutab, Acipen
39. Supraviran
40. Viclovir
41. Vipral
42. Virax Puren
43. Virax-puren
44. Viraxpuren
45. Virherpes
46. Virmen
47. Virolex
48. Virupos
49. Virzin
50. Wellcome 248u
51. Wellcome-248u
52. Wellcome248u
53. Zoliparin
54. Zovirax
55. Zyclir
1. Aciclovir Sodium
2. 69657-51-8
3. Sodium Acyclovir
4. Sodium 2-((2-amino-6-oxo-1h-purin-9(6h)-yl)methoxy)ethanolate
5. Acyclovir Sodium Salt
6. Bw 248u Sodium
7. Mfcd01694138
8. Bw-248u Sodium
9. Bw-248u-sodium
10. Sodium 2-amino-9-((2-hydroxyethoxy)methyl)-9h-purin-6-olate
11. Sodium 2-amino-9-[(2-hydroxyethoxy)methyl]purin-6-olate
12. 9-((2-hydroxyethoxy)methyl)guanine Monosodium Salt
13. Aciclovir Natrium
14. Bw 248u
15. Zovirax Sterile Powder
16. 927l42j563
17. Acycloguanosine Sodium (obs.)
18. Unii-927l42j563
19. 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, Monosodium Salt
20. Schembl40722
21. Chembl1200380
22. Bcp13172
23. Akos015896105
24. 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6h-purin-6-one Monosodium Salt
25. As-12705
26. Sy027836
27. O12074
28. Q27271485
29. Sodium2-amino-9-((2-hydroxyethoxy)methyl)-9h-purin-6-olate
30. 6h-purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-, Monosodium Salt
Molecular Weight | 247.19 g/mol |
---|---|
Molecular Formula | C8H10N5NaO3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 247.06813348 g/mol |
Monoisotopic Mass | 247.06813348 g/mol |
Topological Polar Surface Area | 122 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 237 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Acyclovir sodium |
Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
Active Ingredient | Acyclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
2 of 2 | |
---|---|
Drug Name | Acyclovir sodium |
Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
Active Ingredient | Acyclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-20
Pay. Date : 2013-09-26
DMF Number : 10945
Submission : 1994-06-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11829
Submission : 1996-01-24
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-10-06
Pay. Date : 2020-08-26
DMF Number : 35112
Submission : 2020-08-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40866
Submission : 2024-11-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24289
Submission : 2010-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29995
Submission : 2016-11-28
Status : Active
Type : II
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Dry Powder for Injecti...
Dosage Strength : 500MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Vial
Regulatory Info :
Dosage : Dry Powder for Injecti...
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 400MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : INJECTION
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number : 74885
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number : 74885
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 400mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 400mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 800mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 800mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 800MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 800MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : ACYROVIN
Dosage Form : CREAM
Dosage Strength : 50MG/1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging :
Regulatory Info : Generic
Dosage : CREAM
Dosage Strength : 50MG/1G
Brand Name : ACYROVIN
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : India
Brand Name : CLOVIR
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 200MG
Brand Name : CLOVIR
Approval Date :
Application Number :
Registration Country : India
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
99
PharmaCompass offers a list of Acyclovir Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acyclovir Sodium manufacturer or Acyclovir Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acyclovir Sodium manufacturer or Acyclovir Sodium supplier.
PharmaCompass also assists you with knowing the Acyclovir Sodium API Price utilized in the formulation of products. Acyclovir Sodium API Price is not always fixed or binding as the Acyclovir Sodium Price is obtained through a variety of data sources. The Acyclovir Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Viclovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Viclovir, including repackagers and relabelers. The FDA regulates Viclovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Viclovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Viclovir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Viclovir supplier is an individual or a company that provides Viclovir active pharmaceutical ingredient (API) or Viclovir finished formulations upon request. The Viclovir suppliers may include Viclovir API manufacturers, exporters, distributors and traders.
click here to find a list of Viclovir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Viclovir DMF (Drug Master File) is a document detailing the whole manufacturing process of Viclovir active pharmaceutical ingredient (API) in detail. Different forms of Viclovir DMFs exist exist since differing nations have different regulations, such as Viclovir USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Viclovir DMF submitted to regulatory agencies in the US is known as a USDMF. Viclovir USDMF includes data on Viclovir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Viclovir USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Viclovir suppliers with USDMF on PharmaCompass.
A Viclovir written confirmation (Viclovir WC) is an official document issued by a regulatory agency to a Viclovir manufacturer, verifying that the manufacturing facility of a Viclovir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Viclovir APIs or Viclovir finished pharmaceutical products to another nation, regulatory agencies frequently require a Viclovir WC (written confirmation) as part of the regulatory process.
click here to find a list of Viclovir suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Viclovir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Viclovir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Viclovir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Viclovir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Viclovir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Viclovir suppliers with NDC on PharmaCompass.
Viclovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Viclovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Viclovir GMP manufacturer or Viclovir GMP API supplier for your needs.
A Viclovir CoA (Certificate of Analysis) is a formal document that attests to Viclovir's compliance with Viclovir specifications and serves as a tool for batch-level quality control.
Viclovir CoA mostly includes findings from lab analyses of a specific batch. For each Viclovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Viclovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Viclovir EP), Viclovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Viclovir USP).